Adoptive T-Cell Therapy for Cancer (Q38753404)

2 July 2019

title

Adoptive T-Cell Therapy for Cancer (English)

1 reference

2 July 2019

author name string

James C Yang

series ordinal

1

1 reference

2 July 2019

Steven A Rosenberg

series ordinal

2

1 reference

2 July 2019

publication date

3 February 2016

1 reference

2 July 2019

published in

Advances in Immunology

1 reference

2 July 2019

volume

130

1 reference

2 July 2019

page(s)

279-294

1 reference

2 July 2019

Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19.

cites work

1 reference

12 December 2020

Tumor antigens recognized by T lymphocytes

1 reference

12 December 2020

Tumor infiltrating lymphocyte therapy for metastatic melanoma: analysis of tumors resected for TIL.

1 reference

12 December 2020

The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells

1 reference

12 December 2020

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma

1 reference

12 December 2020

Cancer regression in patients after transfer of genetically engineered lymphocytes

1 reference

12 December 2020

A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma

1 reference

12 December 2020

Production of stable cytolytic T-cell clones directed against autologous human melanoma

1 reference

12 December 2020

Chimeric antigen receptor T cells for sustained remissions in leukemia

1 reference

12 December 2020

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1 reference

12 December 2020

T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis.

1 reference

12 December 2020

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

1 reference

12 December 2020

Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer

1 reference

12 December 2020

Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor

1 reference

12 December 2020

Identification of the genes encoding cancer antigens: implications for cancer immunotherapy.

1 reference

12 December 2020

Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction

1 reference

12 December 2020

Immune resistance orchestrated by the tumor microenvironment

1 reference

12 December 2020

Genetically targeted T cells eradicate systemic acute lymphoblastic leukemia xenografts.

1 reference

12 December 2020

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy

1 reference

12 December 2020

A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response

1 reference

12 December 2020

Therapeutic cancer vaccines: are we there yet?

1 reference

12 December 2020

A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes

1 reference

12 December 2020

IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy

1 reference

12 December 2020

Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma

1 reference

12 December 2020

Tumor-infiltrating lymphocytes genetically engineered with an inducible gene encoding interleukin-12 for the immunotherapy of metastatic melanoma

1 reference

12 December 2020

Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1

1 reference

12 December 2020

Suppressive influences in the immune response to cancer

1 reference

12 December 2020

Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells

1 reference

12 December 2020

Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors

1 reference

12 December 2020

T-cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin 2-dependent T-cell cultures

1 reference

12 December 2020

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report

1 reference

12 December 2020

TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patients.

1 reference

12 December 2020

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

1 reference

12 December 2020

Mutational heterogeneity in cancer and the search for new cancer-associated genes

1 reference

12 December 2020

Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma.

1 reference

12 December 2020

Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy.

1 reference

12 December 2020

Expression of MAGE-A and NY-ESO-1 in Primary and Metastatic Cancers.

1 reference

12 December 2020

Genomic correlates of response to CTLA-4 blockade in metastatic melanoma

1 reference

12 December 2020

The emergence of T-bodies/CAR T cells

1 reference

12 December 2020

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer

1 reference

12 December 2020

Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2

1 reference

12 December 2020

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

1 reference

12 December 2020

Tumor-specific cytolysis by lymphocytes infiltrating human melanomas

1 reference

12 December 2020

Expanding the Reach of Anti-PD-1 Therapy

1 reference

12 December 2020

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

1 reference

12 December 2020

Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes

1 reference

12 December 2020

Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells

1 reference

12 December 2020

1 reference

12 December 2020

10.1016/BS.AI.2015.12.006

Identifiers

DOI

1 reference

2 July 2019

PMCID

6293459

1 reference

2 July 2019

PubMed ID

26923004

1 reference

2 July 2019